van der Gugten J - Search Results

1

5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus.

Compaan JC, Groenink L, van der Gugten J, Maes RA, Olivier B. Compaan JC, et al. Among authors: van der gugten j. Eur J Neurosci. 1996 Nov;8(11):2340-7. doi: 10.1111/j.1460-9568.1996.tb01197.x. Eur J Neurosci. 1996. PMID: 8950098

2

Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations.

Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der Gugten J, Ronken E, Verbeek JS, Veening JG, Dederen PJ, Korosi A, Schoolderman LF, Roubos EW, Olivier B. Dirks A, et al. Among authors: van der gugten j. Eur J Neurosci. 2002 Nov;16(9):1751-60. doi: 10.1046/j.1460-9568.2002.02245.x. Eur J Neurosci. 2002. PMID: 12431228

3

5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety.

Groenink L, Pattij T, De Jongh R, Van der Gugten J, Oosting RS, Dirks A, Olivier B. Groenink L, et al. Among authors: van der gugten j. Eur J Pharmacol. 2003 Feb 28;463(1-3):185-97. doi: 10.1016/s0014-2999(03)01281-0. Eur J Pharmacol. 2003. PMID: 12600710 Review.

4

The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects.

Groenink L, Van der Gugten J, Verdouw PM, Maes RA, Olivier B. Groenink L, et al. Among authors: van der gugten j. Eur J Pharmacol. 1995 Jul 4;280(2):185-93. doi: 10.1016/0014-2999(95)00209-4. Eur J Pharmacol. 1995. PMID: 7589185

5

The corticosterone-enhancing effects of the 5-HT1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT1A receptor.

Groenink L, Van der Gugten J, Mos J, Maes RA, Olivier B. Groenink L, et al. Among authors: van der gugten j. Eur J Pharmacol. 1995 Jan 16;272(2-3):177-83. doi: 10.1016/0014-2999(94)00645-n. Eur J Pharmacol. 1995. PMID: 7713161

6

(S)-UH301, a silent 5-HT1A receptor antagonist, enhances plasma corticosterone levels in the rat.

Groenink L, van der Gugten J, Mos J, Maes RA, Olivier B. Groenink L, et al. Among authors: van der gugten j. Life Sci. 1994;55(5):PL99-103. doi: 10.1016/0024-3205(94)00654-7. Life Sci. 1994. PMID: 8035646

7

Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice.

Groenink L, van der Gugten J, Zethof TJ, van der Heyden JA, Olivier B. Groenink L, et al. Among authors: van der heyden ja, van der gugten j. Pharmacol Biochem Behav. 1996 May;54(1):249-54. doi: 10.1016/0091-3057(95)02177-9. Pharmacol Biochem Behav. 1996. PMID: 8728565

8

The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones.

Groenink L, Mos J, Van der Gugten J, Olivier B. Groenink L, et al. Among authors: van der gugten j. Pharmacol Biochem Behav. 1996 Oct;55(2):303-8. doi: 10.1016/s0091-3057(96)00088-3. Pharmacol Biochem Behav. 1996. PMID: 8951969

9

Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus.

Compaan JC, Groenink L, Van der Gugten J, Maes RA, Olivier B. Compaan JC, et al. Among authors: van der gugten j. Eur J Pharmacol. 1997 Apr 18;324(2-3):161-8. doi: 10.1016/s0014-2999(97)00071-x. Eur J Pharmacol. 1997. PMID: 9145767

10

Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge.

Groenink L, Van der Gugten J, Compaan JC, Maes RA, Olivier B. Groenink L, et al. Among authors: van der gugten j. Psychopharmacology (Berl). 1997 May;131(1):93-100. doi: 10.1007/s002130050270. Psychopharmacology (Berl). 1997. PMID: 9181641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters